Job summary
Job category | Professional (Consulting / Finance / Real Estate / Professional Services)/Professional Services (Health Care / Welfare / Education / Instruction) |
---|---|
Industry | Health Care/ Other Health Care |
Employment type | Uncategorized |
Position level | Director or Above |
Number of openings | 1 |
Desired entry time | - |
Required language skill | |
Foreign language competence | - |
Welfares / Leave systems | |
Assistance in visa application | - |
Number of foreign employees | - |
Work details
Description:
-Japan Project Physician (JPP) is accountable/responsible for the specific Japan expertise of the clinical strategy and program on the responsible products.
i.e., accountable/responsible for
creation of study specification
creation of protocol
study implementation
interpretation of the results
provide contribution to Reg
Response preparation to clinical query
-JPP is a single point of contact on clinical projects
Key Responsibilities:
-Timely provision of Medical Scientific strategies for Japan clinical components of the Clinical Development Plan (CDP) of the Integrated Product Development Plan (iPDP) and Disease Area Strategy and Core labeling texts to the Global Product Teams (iMeds and GMeds) in AZ and Product Development Teams in MedI (PDT)
-Shared view with Clinical Scientists (CS)
-Ensuring Japan project clinical strategies and plans receive peer review including external interactions to assure quality
-Timely input of scientific and medical perspectives into Japan commercial strategy including pricing & value strategy
-Ensure Japan publication plan is appropriate for the Japan medical environment and in alignment with the global publication strategy
-High level strategic external interactions in Japan, including Academic collaborations, Advisory Boards and Key Opinion Leaders
-Maintain and develop the medical and scientific knowledge with the area of expertise
-The JPP is responsible for the ethical integrity of Japan clinical plans and will deliver and own, according to agreed time, cost & quality, the medical scientific strategies for Japan clinical components of the CDP including the Design Specifications (DS) and study Specification (SS) to global Clinical Project Team (CPT)
-Approval of Japan specific part (if applicable) of Investigator Brochure (IB)
-Implementation of Japan Clinical Study specific aspects of the patient risk management plan together with Patient Safety
-Provide medical input to post-marketing clinical studies required by the regulatory authorities and to develop DS/SS, approving Clinical Study Protocol (CSP) and Clinical Study Report (CSR)
-Timely provision of Medical Scientific feasibility etc for Japan externalization projects
-Contribute to ensure the medical accuracy in the development of CSPs (incl. Master Informed Consent Form) and CSRs
-Contribute to and approve the medical content and aspects of Case Report Forms (CRF)s
-Provide tactical medical input for operational matters during the conduct of the study eg advice to Clinical Research Associate (CRA)
-Manage the medical and safety issues surrounding the initiation, execution, and completion of a clinical study
-Set the extended reference range for clinical laboratory data in collaboration with MSD, if needed and review safety information including abnormal clinical laboratory data as a SDT physician
-Review the medical accuracy of IND documentation including preparation of response to Regulatory Authority
-Be medically responsible for investigator meetings
-Japan Medical input to Japan Package Insert changes, PMS studies, Re-evaluation and regulatory queries on the Product
-Contribute to identification of the expected safety risk factors that should be addressed in preparing the patient risk management plan, in cooperation with the global MSD
-Provide medical inputs to activities related to post-marketing surveillance plan and reexamination
Feeder roles:
-The person who meets the requirements above
Measures of Success:
-The context of clinical science input, including scientific risks, mitigations and setting right expectation of clinical development POS, is properly understood by the internal governance bodies for their quality decisions and by the internal stakeholders for the engagement.
-Optimum clinical science strategy is provided for optimum market access of the products within TA portfolio
Reporting Relationship / Team Membership:
-Report to TA Clinical Science Director, Clinical Science Division
-Direct reports: None
About interview
Liaison
Japan Project Physician || 臨床開発医師
RGF HR Agent
1600 〜 2500 ten thousand JPY